Results 321 to 330 of about 12,986,553 (373)
Association of anti-factor Xa-guided anticoagulation with hemorrhage during ECMO support: A systematic review and meta-analysis. [PDF]
Rajsic S +7 more
europepmc +1 more source
Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor-related major bleeding. [PDF]
Lucarelli S +3 more
europepmc +1 more source
Inadequate Anti-Factor Xa Levels With Daily 40-mg Enoxaparin After Cardiac Surgery. [PDF]
Kim H +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Antidote for Factor Xa Anticoagulants
New England Journal of Medicine, 2015Oral anticoagulant options have exploded. Dabigatran, a direct thrombin inhibitor, was approved for use in the United States in 2010 for the prevention of stroke in patients with atrial fibrillation; this was rapidly followed by approval of the direct factor Xa inhibitors rivaroxaban, apixaban, and edoxaban within 5 years. The drive for the development
J. Connors
openaire +3 more sources

